Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among […]
Cardiff Oncology (NASDAQ:CRDF – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Cardiff Oncology to post earnings of ($0.25) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Cardiff Oncology (NASDAQ:CRDF […]
StockNews.com cut shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a sell rating in a report issued on Monday morning. Other equities analysts also recently issued reports about the company. JMP Securities lifted their target price on Kura Oncology from $22.00 to $32.00 and gave the company a market outperform […]
Mural Oncology (NASDAQ:MURA) Earns Overweight Rating from Analysts at Morgan Stanley theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Recommendation of "Moderate Buy" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.